LAVITRANO MARIALUISA

Di Cristofori, A., Ghizzi, M., Raimondo, F., Ramponi, A., Cimino, A., Giambra, M., et al. (2026). Blood derived extracellular vesicles in patients with glioblastoma: preliminary experience from a monoinstitutional series. CLINICAL & TRANSLATIONAL ONCOLOGY [10.1007/s12094-026-04223-w]. Dettaglio

Rossi, F., Fragnito, D., Cruoglio, A., Palombo, R., Massacci, A., Sulis, A., et al. (2025). Implementation of a Digital Maturity Framework for Biobanking. JOURNAL OF BIOMEDICAL INFORMATICS, 166(June 2025) [10.1016/j.jbi.2025.104842]. Dettaglio

Villa, C., Duranti, E., Cadamuro, M., Lavitrano, M. (2025). Riluzole inhibits ovarian cancer cell migration by altering extracellular matrix structure. Intervento presentato a: 37th European Congress of Pathology (ECP) 6–10 September 2025, Vienna, Austria. Dettaglio

Yashooa, R., Duranti, E., Conconi, D., Lavitrano, M., Mustafa, S., Villa, C. (2025). Mitochondrial microRNAs: Key Drivers in Unraveling Neurodegenerative Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(2) [10.3390/ijms26020626]. Dettaglio

Bonomo, S., Giovannoni, R., Lavitrano, M., Cadamuro, M., Conconi, D. (2025). TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(23) [10.3390/ijms262311250]. Dettaglio